{"product_id":"houston-methodist-emerging-topics-in-liver-disease-conference-innovative-trends-in-liver-health-2025","title":"Houston Methodist Emerging Topics in Liver Disease Conference Innovative Trends in Liver Health 2025","description":"\u003cdiv\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"fl-module fl-module-heading fl-node-figwu4oavj0b\" data-node=\"figwu4oavj0b\"\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eHouston Methodist Emerging Topics in Liver Disease Conference Innovative Trends in Liver Health 2025\u003c\/h3\u003e\n\u003cstrong\u003e+ Include: 18 videos + 1 pdf, size: 5.83 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: hepatologists, transplant surgeons, gastroenterologists, hepatology advanced practice providers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"field field-name-event-starts field-type-ds field-label-inline clearfix\"\u003e\n\u003cdiv class=\"field-label\"\u003eEvent starts: 09\/20\/2025 – 7:30am CDT\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"field field-name-event-ends field-type-ds field-label-inline clearfix\"\u003e\n\u003cdiv class=\"field-label\"\u003eEvent ends: 09\/20\/2025 – 4:30pm CDT\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003eThe epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTarget Audience\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse practitioners, and physician assistants and other health care providers.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eAt the conclusion of this activity, the participant should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eProvide significant information regarding new and critical developments in portal hypertension.\u003c\/li\u003e\n\u003cli\u003eIdentify emerging trends in the Metabolic Dysfunction Associated Fatty Liver Disease (MASLD) and determine the latest concepts in diagnosis and management.\u003c\/li\u003e\n\u003cli\u003eExplain innovations occurring in the management of liver diseases, including viral hepatitis.\u003c\/li\u003e\n\u003cli\u003eDiscuss current new developments and treatment of liver cancers –an emerging epidemic.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe Houston Methodist Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2025 is best for hepatologists, transplant surgeons, gastroenterologists, hepatology advanced practice providers, hepatology nurses, transplant coordinators, and researchers seeking focused updates on diagnosis, management, and emerging therapies in liver disease.\u003cbr\u003e\u003ch3\u003eWho should attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatologists and gastroenterologists\u003c\/strong\u003e managing chronic liver disease and complex referrals.\u003c\/li\u003e\n\u003cli class=\"ps-2\"\u003e\n\u003cstrong\u003eTransplant surgeons and transplant teams\u003c\/strong\u003e involved in candidate selection, perioperative care, and outcomes.\u003c\/li\u003e\n\u003cli class=\"ps-2\"\u003e\n\u003cstrong\u003eAdvanced practice providers, nurses, and transplant coordinators\u003c\/strong\u003e delivering multidisciplinary clinical care.\u003c\/li\u003e\n\u003cli class=\"ps-2\"\u003e\n\u003cstrong\u003eClinical researchers and trainees\u003c\/strong\u003e interested in translational advances and new diagnostics or therapeutics.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl79\" colspan=\"3\"\u003e\u003cstrong\u003eEmerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2025\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl83\" colspan=\"3\"\u003e\n\u003cstrong\u003eAGENDA\u003c\/strong\u003e | Saturday, September 20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl77\"\u003e\u003cstrong\u003eTIME\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"xl77\"\u003e\u003cstrong\u003ePRESENTATION\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"xl77\"\u003e\u003cstrong\u003eSPEAKER(S)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl73\"\u003e7:00 AM\u003c\/td\u003e\n\u003ctd class=\"xl81\" colspan=\"2\"\u003eRegistration \u0026amp; Breakfast\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e7:30 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\"\u003eConference Welcome\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eVictor Ankoma-Sey, MD, FACP, FAASLD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e7:40 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\"\u003eIntroductory Remarks\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eR. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl84\" colspan=\"3\"\u003e\n\u003cstrong\u003ePLENARY SESSION I: Unique Complications of Portal Hypertension \u003c\/strong\u003eModerators: Chukwuma Egwim, MD, Joseph Galati, MD and Ashish Saharia, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e7:50 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\"\u003eDrug induced liver injury in the patient with Chronic liver disease\u003c\/td\u003e\n\u003ctd class=\"xl78\"\u003eNaga Chalasani, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e8:20 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\"\u003e\n\u003cstrong\u003eState of the Art Lecture I \u003c\/strong\u003eManagement of Coagulopathy \u0026amp; Bleeding Diathesis in the patient with Cirrhosis\u003c\/td\u003e\n\u003ctd class=\"xl75\"\u003ePatrick Northup, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e8:50 AM\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eFrom Risk to Recognition: Addressing Emerging Threats to Improve Prevention and Detection of HCC\u003c\/td\u003e\n\u003ctd class=\"xl75\"\u003eCynthia Ann Moylan, MD, MHS, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e9:10 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\" colspan=\"2\"\u003eQ\u0026amp;A and Discussion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl73\"\u003e9:25 AM\u003c\/td\u003e\n\u003ctd class=\"xl81\" colspan=\"2\"\u003eBREAK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl84\" colspan=\"3\"\u003e\n\u003cstrong\u003ePLENARY SESSION II: Advances in Metabolic Dysfunction-Associated Fatty liver Disease (MASLD) – What’s New? \u003c\/strong\u003eModerators: Victor Ankoma-Sey, MD, Tamneet Basra, MD and Constance Mobley, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e9:40 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\"\u003eEndocrine Aspects of MASLD \u0026amp; Obesity: 2025 Update\u003c\/td\u003e\n\u003ctd class=\"xl70\"\u003eArun Sanyal, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e10:10 AM\u003c\/td\u003e\n\u003ctd class=\"xl69\"\u003eNoninvasive Assessment of Fibrosis in MASLD\u003c\/td\u003e\n\u003ctd class=\"xl70\"\u003eElliot Tapper, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e10:40 AM\u003c\/td\u003e\n\u003ctd class=\"xl69\"\u003e\n\u003cstrong\u003eState of the Art Lecture II \u003c\/strong\u003eCurrent and Future Treatment Options of MASLD\u003c\/td\u003e\n\u003ctd class=\"xl70\"\u003eManal Abdelmalek, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e11:10 AM\u003c\/td\u003e\n\u003ctd class=\"xl69\"\u003eThe patient with MASLD and concomitant Alcohol Associated Liver Disease or HBV or HCV – What to do?\u003c\/td\u003e\n\u003ctd class=\"xl70\"\u003eMichelle Jones Pauley, DO , MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e11:30 AM\u003c\/td\u003e\n\u003ctd class=\"xl76\" colspan=\"2\"\u003eQ\u0026amp;A and Discussion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl73\"\u003e11:45 AM\u003c\/td\u003e\n\u003ctd class=\"xl81\" colspan=\"2\"\u003eLUNCH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl73\"\u003e11:45 AM\u003c\/td\u003e\n\u003ctd class=\"xl74\"\u003ePRODUCT THEATRE (Presented in Boardroom)\u003c\/td\u003e\n\u003ctd class=\"xl74\"\u003eFernando Membreno, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl84\" colspan=\"3\"\u003e\n\u003cstrong\u003ePLENARY SESSION III: Current Innovations in Liver Disease \u003c\/strong\u003eModerators: Mark Ghobrial, MD, Caroline Simon, MD \u0026amp; Andrea Duchini, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e12:45 PM\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003e\n\u003cstrong\u003eState of the Art Lecture III \u003c\/strong\u003eThe Future of Liver transplantation\u003c\/td\u003e\n\u003ctd class=\"xl71\"\u003eR. Mark Ghobrial, MD, PhD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e1:05 PM\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eRole of Artificial Intelligence (AI) in the management of liver disease\u003c\/td\u003e\n\u003ctd class=\"xl71\"\u003eDavid Victor III, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e1:25 PM\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eLiving Donor Liver Transplant – A new Era\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eYee Lee Cheah, MD, FACS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e1:45 PM\u003c\/td\u003e\n\u003ctd class=\"xl68\"\u003eThe role of liver transplantation in the management of Cholangiocarcinoma\u003c\/td\u003e\n\u003ctd class=\"xl71\"\u003eAshton Connor, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e2:15 PM\u003c\/td\u003e\n\u003ctd class=\"xl69\" colspan=\"2\"\u003eQ\u0026amp;A and Discussion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl73\"\u003e2:30 PM\u003c\/td\u003e\n\u003ctd class=\"xl81\" colspan=\"2\"\u003eBREAK\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl84\" colspan=\"3\"\u003e\n\u003cstrong\u003ePLENARY SESSION IV: Liver Cancer- Current Concepts \u003c\/strong\u003eModerators: Sudha Kodali, MD, Julie Corkrean \u0026amp; Julie Luczon\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e2:45 PM\u003c\/td\u003e\n\u003ctd class=\"xl72\"\u003eSurveillance \u0026amp; Diagnosis of Hepatocellular Cancer – What is new?\u003c\/td\u003e\n\u003ctd class=\"xl71\"\u003eLewis Roberts, MB, ChB, PHD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e3:15 PM\u003c\/td\u003e\n\u003ctd class=\"xl72\"\u003e\n\u003cstrong\u003eState of the Art Lecture IV \u003c\/strong\u003eManagement of Hepatocellular carcinoma- Role of immunotherapy\u003c\/td\u003e\n\u003ctd class=\"xl67\"\u003eAhmed Omar Kaseb, MD, CMQ\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e3:45 PM\u003c\/td\u003e\n\u003ctd class=\"xl72\"\u003eCurrent and Future Management of Cholangiocarcinoma, a model for personalized Medicine?\u003c\/td\u003e\n\u003ctd class=\"xl67\"\u003eSudha Kodali, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl66\"\u003e4:15 PM\u003c\/td\u003e\n\u003ctd class=\"xl69\" colspan=\"2\"\u003eQ\u0026amp;A and Discussion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"xl73\"\u003e4:30 PM\u003c\/td\u003e\n\u003ctd class=\"xl82\" colspan=\"2\"\u003eCONCLUDING REMARKS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662753419593,"sku":"MED-AMB05728","price":25.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Houston-Methodist-Emerging-Topics-in-Liver-Disease-Conference-Innovative-Trends-in-Liver-Health-2025.jpg?v=1781874129","url":"https:\/\/medicalducation.com\/products\/houston-methodist-emerging-topics-in-liver-disease-conference-innovative-trends-in-liver-health-2025","provider":"Medical Education Hub","version":"1.0","type":"link"}